ICYMI: Eli Lilly's New Weight Loss Pill | Bloomberg Businessweek скачать в хорошем качестве

ICYMI: Eli Lilly's New Weight Loss Pill | Bloomberg Businessweek

Shares in Eli Lilly surged on Friday after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai Pharmaceutical Co. also soared. The triumph of Ozempic, the blockbuster diabetes shot from Novo Nordisk A/S, and related drugs including Zepbound and Mounjaro from Lilly, has set off an all-out push to develop a pill that’s easier to take and less expensive to make. While rivals including Pfizer Inc. have suffered setbacks, analysts said success is critical to creating the $130 billion market they predict by the end of the decade. Hosts Carol Massar and Tim Stenovec speak with Bloomberg's Damian Garde about the new pill could mean for Eli Lilly. See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors. Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts Listen to more of Bloomberg Businessweek:    • Bloomberg Businessweek   #Bloomberg #Podcast #News #Businessweek Visit us: https://www.bloomberg.com/podcasts Follow Bloomberg Podcasts on Twitter:   / podcasts   Visit our other YouTube channels: Bloomberg Television:    / @markets   Bloomberg Originals:    / bloomberg   Quicktake:    / @bloombergquicktake   For coverage on news, markets and more: http://www.bloomberg.com/video